$782.040
-8.602 (-1.10%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
REGN Prediction & Forecast by Similar Chart Analysis
Alphio's REGN stock price prediction model matches the current Regeneron Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $782.98 (+0.12%). The 1-week path is $762.02 (-2.56%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Regeneron Pharmaceuticals Inc Stock?
Regeneron Pharmaceuticals Inc is a good buy right now, trading at $790.74 with a strong forward P/E of 14.51, indicating potential for earnings growth. The recent positive Phase 3 trial results for Pasatru highlight significant efficacy, which could drive future revenue. Additionally, hedge funds have increased their buying activity by 167% over the last quarter, suggesting strong institutional confidence. However, the RSI is at 69.33, indicating that the stock may be nearing overbought territory, which is a risk to consider.
REGN stock price ended at $782.04 on Monday, after losing -1.10%
Regeneron Pharmaceuticals Inc (REGN) last closed at $782.04, losing -1.10%. These facts feed the 1-day and 1-week REGN price prediction above.
Analyst Consensus
Regeneron Pharmaceuticals Inc (REGN): 13 buy, 12 hold, 1 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Regeneron Pharmaceuticals Inc (REGN) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches REGN, ranked by similarity.
Seasonality analysis for REGN
Historically the probability of a positive October return for REGN is 44.07%. August offers the highest probability of a positive month at 60.94%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for REGN
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $532.77 | $606.87 | $618.10 | -22.40% |
| Nov 2026 | $582.01 | $654.23 | $691.74 | -16.34% |
| Dec 2026 | $606.44 | $711.92 | $785.14 | -8.97% |
In 2026, Regeneron Pharmaceuticals Inc (REGN) is projected to range from $532.77 to $785.14.
Regeneron Pharmaceuticals Inc 2026 monthly forecast
In Oct 2026, Regeneron Pharmaceuticals Inc is projected to average $606.87, with a low of $532.77 and high of $618.10.
In Nov 2026, Regeneron Pharmaceuticals Inc is projected to average $654.23, with a low of $582.01 and high of $691.74.
In Dec 2026, Regeneron Pharmaceuticals Inc is projected to average $711.92, with a low of $606.44 and high of $785.14.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.